BREAST CANCER RES
Journal Abbreviation: BREAST CANCER RES
ISSN: 1465-5411
Publisher: BioMed Central
Publications (5)
Dynamics of T cell subpopulations and plasma cytokines during the first year of antineoplastic therapy in patients with breast cancer: the BEGYN-1 study (2025)
Kaiser E, Weber R, Hirschstein M, Mazid H, Kapps EMS, Hans MC, Bous M, et al.
Journal article
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (Breast Cancer Research, (2022), 24, 1, (69), 10.1186/s13058-022-01567-3) (2022)
Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BA, Becher H, Blomqvist C, et al.
Journal article, Erratum
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021)
Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, et al.
Journal article
Human leucocyte antigen class i in hormone receptor-positive, HER2-negative breast cancer: Association with response and survival after neoadjuvant chemotherapy (2019)
Sinn BV, Weber KE, Schmitt WD, Fasching P, Symmans WF, Blohmer JU, Karn T, et al.
Journal article
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth (2018)
Mao SPH, Park M, Cabrera RM, Christin JR, Karagiannis GS, Oktay MH, Zaiss DMW, et al.
Journal article